为系统性红斑狼疮患者制定个体化心血管风险预测
研究基于布莱根妇女医院系统性红斑狼疮(SLE)队列开发SLE专用心血管风险预测工具SLECRISK,用于预测10年主要不良心血管事件(MACE)中/高风险(≥7.5%)。纳入1243例患者、随访8946.5人年发生90例MACE,SLECRISK灵敏度0.74(95%CI:0.65,0.83),高于ACC/AHA模型0.38(95%CI:0.28,0.48),识别中/高风险患者数为ACC/AHA的3.4倍。
要点
- SLECRISK预测10年MACE中/高风险(≥7.5%)的灵敏度为0.74(95%CI:0.65,0.83)。
- ACC/AHA模型灵敏度为0.38(95%CI:0.28,0.48),SLECRISK高于ACC/AHA。
- SLECRISK识别中/高风险患者数为ACC/AHA的3.4倍。
核心结论
- 新型SLECRISK工具预测10年MACE中/高风险比ACC/AHA更敏感,可能对年轻女性重症SLE的风险预测特别有用。
- 未来需要利用SLE更重的队列进行外部验证研究。
研究设计与样本
- 研究纳入布莱根妇女医院SLE队列患者,收集入组时一年基线数据(传统心血管病因素及SLE相关特征)。
- 从基线期后第1天(索引日期)开始随访10年,记录首个MACE(心肌梗死、卒中或心源性死亡)。
- MACE由经委员会认证的心脏科医生裁定,ICD-9/10编码用于识别MACE。
- 采用最小绝对收缩和选择算子回归筛选SLE相关变量,加入ACC/AHA汇总队列风险方程10年风险Cox回归模型。
- 使用自举法进行乐观度调整的内部验证。
主要发现
- 共纳入1243例患者,随访8946.5人年,发生90例MACE(46例心肌梗死、36例卒中、19例心源性死亡)。
- SLECRISK选入的SLE变量包括SLE活动度(缓解/轻度 vs 中度/重度)、病程(年)、肌酐(mg/dL)、抗dsDNA、抗RNP、狼疮抗凝物、抗Ro阳性及低C4。
- SLECRISK预测10年MACE中/高风险(≥7.5%)的灵敏度为0.74(95%CI:0.65,0.83),ACC/AHA模型为0.38(95%CI:0.28,0.48)。
- SLECRISK识别中/高风险患者数为ACC/AHA的3.4倍。
- 按SLECRISK为中/高风险但按ACC/AHA非中/高风险的患者,更可能是年轻女性、重症SLE且其他传统心血管病危险因素少。
关键数值与推荐
- MACE定义为心肌梗死、卒中或心源性死亡。
- 中/高风险定义为10年MACE风险≥7.5%。
- SLECRISK灵敏度0.74(95%CI:0.65,0.83) vs ACC/AHA灵敏度0.38(95%CI:0.28,0.48)。
- SLECRISK识别中/高风险患者数为ACC/AHA的3.4倍。
临床怎么用
- 原文未据此给出推荐。
局限性
- 未来需要利用SLE更重的队列进行外部验证研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Cardiovascular disease (CVD) risk is increased in SLE and underestimated by general population prediction algorithms. We aimed to develop a novel SLE-specific prediction tool, SLECRISK, to provide a more accurate estimate of CVD risk in SLE. METHODS: We studied patients in the Brigham and Women's Hospital SLE cohort. We collected one-year baseline data including the presence of traditional CVD factors and SLE-related features at cohort enrollment. Ten-year follow-up for the first major adverse cardiovascular event (MACE; myocardial infarction (MI), stroke, or cardiac death) began at day +1 following the baseline period (index date). ICD-9/10 codes identified MACE were adjudicated by board-certified cardiologists. Least absolute shrinkage and selection operator regression selected SLE-related variables to add to the American College of Cardiology/American Heart Association (ACC/AHA) Pooled Cohort Risk Equations 10-year risk Cox regression model. Model fit statistics and performance (sensitivity, specificity, positive/negative predictive value, c-statistic) for predicting moderate/high 10-year risk (≥7.5 %) of MACE were assessed and compared to ACC/AHA, Framingham risk score (FRS), and modified FRS (mFRS). Optimism adjustment internal validation was performed using bootstrapping. RESULTS: We included 1,243 patients with 90 MACEs (46 MIs, 36 strokes, 19 cardiac deaths) over 8946.5 person-years of follow-up. SLE variables selected for the new prediction algorithm (SLECRISK) were SLE activity (remission/mild vs. moderate/severe), disease duration (years), creatinine (mg/dL), anti-dsDNA, anti-RNP, lupus anticoagulant, anti-Ro positivity, and low C4. The sensitivity for detecting moderate/high-risk (≥7.5 %) of MACE using SLECRISK was 0.74 (95 %CI: 0.65, 0.83), which was better than the sensitivity of the ACC/AHA model (0.38 (95 %CI: 0.28, 0.48)). It also identified 3.4-fold more moderate/high-risk patients than the ACC/AHA. Patients who were moderate/high-risk according to SLECRISK but not ACC/AHA, were more likely to be young women with severe SLE and few other traditional CVD risk factors. Model performance between SLECRISK, FRS, and mFRS were similar. CONCLUSION: The novel SLECRISK tool is more sensitive than the ACC/AHA for predicting moderate/high 10-year risk for MACE and may be particularly useful in predicting risk for young females with severe SLE. Future external validation studies utilizing cohorts with more severe SLE are needed.
引用
- Choi MY, Guan H, Yoshida K, et al. Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2024. PMID: 38788567. doi:10.1016/j.semarthrit.2024.152468
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。